Sunshine Biopharma Inc. (SBFM) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Sunshine Biopharma Inc.

    NASDAQ: SBFM · Real-Time Price · USD
    1.36
    -0.07 (-4.90%)
    At close: Sep 05, 2025, 3:56 PM
    1.42
    4.73%
    After-hours: Sep 05, 2025, 06:19 PM EDT

    Sunshine Biopharma Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 9.69M 16.29M 21.83M 2.05M
    Short-Term Investments
    		 n/a n/a n/a 7.59K
    Long-Term Investments
    		 n/a n/a 1.63M n/a
    Other Long-Term Assets
    		 n/a n/a -1.93M -7.06K
    Receivables
    		 3.87M 2.55M 1.91M 7.8K
    Inventory
    		 11.28M 5.73M 3.29M 105.65K
    Other Current Assets
    		 n/a n/a n/a 7.59K
    Total Current Assets
    		 25.97M 24.89M 27.31M 2.2M
    Property-Plant & Equipment
    		 1.48M 1.01M 1.15M 7.06K
    Goodwill & Intangibles
    		 3.02M 1.44M 776.86K n/a
    Total Long-Term Assets
    		 4.59M 2.46M 1.93M 7.06K
    Total Assets
    		 30.56M 27.35M 29.24M 2.2M
    Account Payables
    		 5.54M 2.59M 2.8M 42.94K
    Deferred Revenue
    		 n/a n/a n/a n/a
    Short-Term Debt
    		 n/a n/a 3.63M n/a
    Other Current Liabilities
    		 295.8K 2.55M n/a n/a
    Total Current Liabilities
    		 6.31M 5.55M 6.93M 91.23K
    Long-Term Debt
    		 n/a n/a n/a 1.9M
    Other Long-Term Liabilities
    		 n/a n/a n/a n/a
    Total Long-Term Liabilities
    		 744.72K 587.76K 685.26K 1.9M
    Total Liabilities
    		 7.06M 6.14M 7.62M 1.99M
    Total Debt
    		 952.48K 657.71K 4.27M 1.9M
    Common Stock
    		 2.58K 28.02K 22.59K 2.59K
    Retained Earnings
    		 -69.04M -63.91M -59.4M -32.66M
    Comprehensive Income
    		 -829.96K 696.11K 161.85K -23.14K
    Shareholders Equity
    		 23.5M 21.21M 21.63M 211.66K
    Total Investments
    		 n/a n/a 1.63M 7.59K

    Add to Watchlist